학술논문

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma
Document Type
Artikel
Source
Cancer medicine. 12(22):20736-20744
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2045-7634